Monday, 17 August 2026
Afghanistan's healthcare system crisis, WHO's syphilis elimination challenges, Upadacitinib for non-segmental vitiligo
- 01
Afghanistan's health system faces mounting pressures post-Taliban takeover
Afghanistan's health system is under increasing strain due to restrictions on women and girls, significant cuts to international aid, closures of health facilities, and mass returns of displaced individuals. These factors contribute to deteriorating health conditions in the country. The situation highlights the fragility of Afghanistan's healthcare infrastructure five years after the Taliban's takeover.
via The Lancet
- 02
WHO's syphilis elimination efforts fall short of targets
The World Health Organization's initiatives to eliminate syphilis are significantly off target, according to a report by Sophie Cousins. This resurgence of syphilis poses a critical public health challenge globally. The situation highlights the ongoing need for effective screening and treatment strategies. The implications for public health are substantial, affecting various populations.
via The Lancet
- 03
Upadacitinib shows promise for treating non-segmental vitiligo
Upadacitinib 15 mg daily resulted in clinically meaningful repigmentation of both the face and total body in adults and adolescents with non-segmental vitiligo. The findings emerged from two phase 3 randomised controlled studies. No new safety signals were identified during the trials, indicating a favourable safety profile. These results may influence future management strategies for patients with this condition.
via The Lancet
- 04
Report on Drug-Induced Subacute Cutaneous Lupus Erythematosus Released
A report detailing drug-induced subacute cutaneous lupus erythematosus has been published in the New England Journal of Medicine. The findings may offer insights into drug reactions and patient management. Further details on the specific drugs involved or clinical implications were not provided in the source.
via NEJM
- 05
Discussion on Marijuana Rescheduling Emerges in NEJM
An editorial in the New England Journal of Medicine discusses the potential implications of marijuana rescheduling for research and prescribing practices. The evolving regulations surrounding cannabis could significantly impact how it is studied and prescribed. This conversation may influence future clinical practices and research directions in Australia.
via NEJM
- 06
Discussion on Marijuana Rescheduling and Research Implications
The New England Journal of Medicine has published an article discussing the potential impact of marijuana rescheduling on research. The piece argues that changing the scheduling of marijuana could significantly enhance research opportunities. This development may influence health policies and practices, particularly in the context of equitable care. The article underscores the importance of inclusive health policies in advancing research.
via NEJM
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.